Remimazolam: The future of its sedative potential
Remimazolam (CNS 7056) is a new drug innovation in anesthesia. It combines the properties of two unique drugs already established in anesthesia - Midazolam and remifentanil. It acts on GABA receptors like midazolam and has organ-independent metabolism like remifentanil. It is likely to be the sedati...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | Saudi Journal of Anaesthesia |
Subjects: | |
Online Access: | http://www.saudija.org/article.asp?issn=1658-354X;year=2014;volume=8;issue=3;spage=388;epage=391;aulast=Goudra |